A Progesterone Receptor Co-activator (JDP2) Mediates Activity through Interaction with Residues in the Carboxyl-terminal Extension of the DNA Binding Domain♦

Progesterone receptor (PR) belongs to the nuclear receptor family of ligand-dependent transcription factors and mediates the major biological effects of progesterone. Transcriptional co-activators that are recruited by PR through the carboxyl-terminal ligand binding domain have been studied extensively. Much less is known about co-activators that interact with other regions of receptors. Jun dimerization protein 2 (JDP2) is a PR co-activator that enhances the transcriptional activity of the amino-terminal domain by increasing the α-helical content and stability of the intrinsically disordered amino-terminal domain. To gain insights into the mechanism of JDP2 co-activation of PR, the structural basis of JDP2-PR interaction was analyzed using NMR. The smallest regions of each protein needed for efficient protein interaction were used for NMR and included the basic region plus leucine zipper (bZIP) domain of JDP2 and the core zinc modules of the PR DNA binding domain plus the intrinsically disordered carboxyl-terminal extension (CTE) of the DNA binding domain. Chemical shift changes in PR upon titration with JDP2 revealed that most of the residues involved in binding of JDP2 reside within the CTE. The importance of the CTE for binding JDP2 was confirmed by peptide competition and mutational analyses. Point mutations within CTE sites identified by NMR and a CTE domain swapping experiment also confirmed the functional importance of JDP2 interaction with the CTE for enhancement of PR transcriptional activity. These studies provide insights into the role and functional importance of the CTE for co-activator interactions.

[1]  Yoshitomo Hamuro,et al.  Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA , 2008, Nature.

[2]  David S. Wishart,et al.  CS23D: a web server for rapid protein structure generation using NMR chemical shifts and sequence data , 2008, Nucleic Acids Res..

[3]  D. Edwards,et al.  Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding , 2008, Nucleic acids research.

[4]  R. Lanz,et al.  Nuclear receptor coregulators and human disease. , 2008, Endocrine reviews.

[5]  V. Hilser,et al.  Intrinsic disorder as a mechanism to optimize allosteric coupling in proteins , 2007, Proceedings of the National Academy of Sciences.

[6]  David S. Wishart,et al.  The RCI server: rapid and accurate calculation of protein flexibility using chemical shifts , 2007, Nucleic Acids Res..

[7]  Christopher J. Oldfield,et al.  Intrinsic disorder and functional proteomics. , 2007, Biophysical journal.

[8]  D. Edwards,et al.  Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements. , 2006, Molecular endocrinology.

[9]  I. McEwan,et al.  The human androgen receptor AF1 transactivation domain: interactions with transcription factor IIF and molten-globule-like structural characteristics. , 2006, Biochemical Society transactions.

[10]  I. McEwan,et al.  The role of the general transcription factor IIF in androgen receptor-dependent transcription. , 2006, Molecular endocrinology.

[11]  K. Struhl,et al.  Differential Gene Regulation by Selective Association of Transcriptional Coactivators and bZIP DNA-Binding Domains , 2006, Molecular and Cellular Biology.

[12]  David S. Wishart,et al.  PREDITOR: a web server for predicting protein torsion angle restraints , 2006, Nucleic Acids Res..

[13]  Christopher J. Oldfield,et al.  Intrinsic disorder in transcription factors. , 2006, Biochemistry.

[14]  Raj Kumar,et al.  Activation function 1 of glucocorticoid receptor binds TATA-binding protein in vitro and in vivo. , 2006, Molecular endocrinology.

[15]  Eric D. Ross,et al.  Intrinsic Protein Disorder, Amino Acid Composition, and Histone Terminal Domains* , 2006, Journal of Biological Chemistry.

[16]  Sonia Longhi,et al.  Assessing protein disorder and induced folding , 2005, Proteins.

[17]  D. Edwards,et al.  Regulation of the Amino-Terminal Transcription Activation Domain of Progesterone Receptor by a Cofactor-Induced Protein Folding Mechanism , 2005, Molecular and Cellular Biology.

[18]  Arash Bahrami,et al.  Probabilistic Identification of Spin Systems and their Assignments including Coil–Helix Inference as Output (PISTACHIO) , 2005, Journal of biomolecular NMR.

[19]  J. Markley,et al.  Protein energetic conformational analysis from NMR chemical shifts (PECAN) and its use in determining secondary structural elements , 2005, Journal of biomolecular NMR.

[20]  H. Dyson,et al.  Intrinsically unstructured proteins and their functions , 2005, Nature Reviews Molecular Cell Biology.

[21]  D. Volk,et al.  TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Tom Maniatis,et al.  Crystal structure of ATF‐2/c‐Jun and IRF‐3 bound to the interferon‐β enhancer , 2004 .

[23]  W. Scovell,et al.  High mobility group B proteins facilitate strong estrogen receptor binding to classical and half-site estrogen response elements and relax binding selectivity. , 2004, Molecular Endocrinology.

[24]  J. Yates,et al.  A novel estrogen receptor alpha-associated protein alters receptor-deoxyribonucleic acid interactions and represses receptor-mediated transcription. , 2004, Molecular endocrinology.

[25]  D. Edwards,et al.  The Role of the C-terminal Extension (CTE) of the Estrogen Receptor α and β DNA Binding Domain in DNA Binding and Interaction with HMGB* , 2004, Journal of Biological Chemistry.

[26]  Raj Kumar,et al.  Induced alpha-helix structure in AF1 of the androgen receptor upon binding transcription factor TFIIF. , 2004, Biochemistry.

[27]  B. O’Malley,et al.  Unfolding the Action of Progesterone Receptors* , 2003, Journal of Biological Chemistry.

[28]  J. Gustafsson,et al.  Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. , 2003, Molecular endocrinology.

[29]  H. Dyson,et al.  Monomeric complex of human orphan estrogen related receptor-2 with DNA: a pseudo-dimer interface mediates extended half-site recognition. , 2003, Journal of molecular biology.

[30]  David S Wishart,et al.  RefDB: A database of uniformly referenced protein chemical shifts , 2003, Journal of biomolecular NMR.

[31]  D. Edwards,et al.  Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  D. Edwards,et al.  Jun Dimerization Protein 2 Functions as a Progesterone Receptor N-Terminal Domain Coactivator , 2002, Molecular and Cellular Biology.

[33]  D. Edwards,et al.  The C-terminal Extension (CTE) of the Nuclear Hormone Receptor DNA Binding Domain Determines Interactions and Functional Response to the HMGB-1/-2 Co-regulatory Proteins* , 2002, The Journal of Biological Chemistry.

[34]  D. Gewirth,et al.  Structural basis of VDR–DNA interactions on direct repeat response elements , 2002, The EMBO journal.

[35]  T. Härd,et al.  The N-terminal Regions of Estrogen Receptor α and β Are Unstructured in Vitro and Show Different TBP Binding Properties* , 2001, The Journal of Biological Chemistry.

[36]  R. Evans,et al.  Nuclear receptors and lipid physiology: opening the X-files. , 2001, Science.

[37]  S. Khorasanizadeh,et al.  Nuclear-receptor interactions on DNA-response elements. , 2001, Trends in biochemical sciences.

[38]  H. Gronemeyer,et al.  Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. , 2000, Trends in pharmacological sciences.

[39]  O. Jänne,et al.  The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor. , 2000, Journal of cell science.

[40]  S. Wolfe,et al.  Structural studies of the high mobility group globular domain and basic tail of HMG-D bound to disulfide cross-linked DNA. , 2000, Biochemistry.

[41]  M. Beato,et al.  Steroid hormone receptors: an update. , 2000, Human reproduction update.

[42]  S. Khorasanizadeh,et al.  Structure of the RXR–RAR DNA‐binding complex on the retinoic acid response element DR1 , 2000, The EMBO journal.

[43]  M. Sierk,et al.  Structural basis of RXR-DNA interactions. , 2000, Journal of molecular biology.

[44]  O. Jänne,et al.  Coregulator Small Nuclear RING Finger Protein (SNURF) Enhances Sp1- and Steroid Receptor-mediated Transcription by Different Mechanisms* , 2000, The Journal of Biological Chemistry.

[45]  M. Galligan,et al.  Characterization of unique DNA-binding and transcriptional-activation functions in the carboxyl-terminal extension of the zinc finger region in the human vitamin D receptor. , 1999, Biochemistry.

[46]  P. Sigler,et al.  DNA-binding mechanism of the monomeric orphan nuclear receptor NGFI-B , 1999, Nature Structural Biology.

[47]  David A. Agard,et al.  The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.

[48]  O. Jänne,et al.  Identification of a Novel RING Finger Protein as a Coregulator in Steroid Receptor-Mediated Gene Transcription , 1998, Molecular and Cellular Biology.

[49]  D. Edwards,et al.  High-Mobility Group Chromatin Proteins 1 and 2 Functionally Interact with Steroid Hormone Receptors To Enhance Their DNA Binding In Vitro and Transcriptional Activity in Mammalian Cells , 1998, Molecular and Cellular Biology.

[50]  S. Minucci,et al.  The histone acetylase PCAF is a nuclear receptor coactivator. , 1998, Genes & development.

[51]  M. Lazar,et al.  Structural elements of an orphan nuclear receptor-DNA complex. , 1998, Molecular cell.

[52]  Jeffrey A. Lefstin,et al.  Allosteric effects of DNA on transcriptional regulators , 1998, Nature.

[53]  S. Harrison,et al.  Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA , 1998, Nature.

[54]  S. Kliewer,et al.  NMR Spectroscopic Studies of the DNA-binding Domain of the Monomer-binding Nuclear Orphan Receptor, Human Estrogen Related Receptor-2 , 1997, The Journal of Biological Chemistry.

[55]  S. Elledge,et al.  Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions , 1997, Molecular and cellular biology.

[56]  G. Verdine,et al.  A critical arginine residue mediates cooperativity in the contact interface between transcription factors NFAT and AP-1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[57]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[58]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[59]  H. Gronemeyer,et al.  How to finger DNA , 1995, Nature.

[60]  S. Kliewer,et al.  Structure of the retinoid X receptor alpha DNA binding domain: a helix required for homodimeric DNA binding. , 1993, Science.

[61]  H. Gronemeyer,et al.  A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. , 1992, The Journal of biological chemistry.

[62]  J. Milbrandt,et al.  Participation of non-zinc finger residues in DNA binding by two nuclear orphan receptors. , 1992, Science.

[63]  Raj Kumar,et al.  Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions. , 2003, Molecular endocrinology.

[64]  W. Chin,et al.  Identification and Characterization of a Tissue-Specific Coactivator, GT198, That Interacts with the DNA-Binding Domains of Nuclear Receptors , 2022 .